|
Post by peppy on Oct 15, 2021 18:27:06 GMT -5
Technically, the daily makes the weekly look better. The daily says Back Test. Price needs to hold the line for the pattern to proceed. MNKD Nasdaq real time volume, 3,229,289 MNKD Nasdaq summary volume, 4,790,181 Avg. Volume 2,557,020 Today was options expiry, (thank you for mentioning.) Charts, daily weekly.
|
|
|
Post by hellodolly on Oct 15, 2021 18:51:16 GMT -5
peppy What I like about this week, on the daily chart, is instead of a swing to another lower high and a tighter consolidation, we broke through the symmetrical triangle and made a higher high. The higher lows have been coming all along the whole year. This was nice to see it form a new area of value.
|
|
|
Post by peppy on Oct 18, 2021 8:47:21 GMT -5
4,258,280 Avg. Volume 2,622,304 In 15 mins.
4.35 -0.74 (-14.5383%) Pre-Market: 09:29AM EDT
MNKD is being bought now. or I am waiting for MNKD to be bought.
|
|
|
Post by peppy on Oct 18, 2021 9:30:44 GMT -5
MNKD Volume @ 1 hour of trade, real time, 4,604,943 summary, 7,362,210 Avg. Volume 2,622,304
$4.0800. -1.0100 (-19.8428%) As of 10:30AM EDT. Market open.
added, volume at 2 hours of trade, real time, 6,809,635 summary, 10,889,752
$4.1250. -0.9650 (-18.9587%) As of 11:30AM EDT. Market open.
|
|
|
Post by boca1girl on Oct 18, 2021 9:54:24 GMT -5
So where is support Peppy? Looks like the stock price fell below all of the colored lines on your charts.
I hope we’re not looking at 2.82.
|
|
|
Post by peppy on Oct 18, 2021 9:56:16 GMT -5
So where is support Peppy? Looks like the stock price fell below all of the colored lines on your charts. I hope we’re not looking at 2.82. actually Boca, take a look, not all is lost.
|
|
|
Post by joeypotsandpans on Oct 18, 2021 10:04:55 GMT -5
So where is support Peppy? Looks like the stock price fell below all of the colored lines on your charts. I hope we’re not looking at 2.82. actually Boca, take a look, not all is lost. I cashed in my WSOP tournament yesterday, 1 guess where that money's is going...on another note, I still have 100 Nov 2 calls that i plan on exercising...this is an absolute gift IMO, will also be looking at the premium on the 4 PUT expiry's
|
|
|
Post by cretin11 on Oct 18, 2021 10:35:46 GMT -5
Those $4 put premiums will look even better if/when we slide into the 3s.
|
|
|
Post by boca1girl on Oct 18, 2021 10:42:18 GMT -5
I’ve got a protective buy order (gtc) at $3.75.
Many on the board think we drift down to $3.50 because they see no catalysts between now and Tre-T approval. Who knows, MNKD might drift down that low, but I don’t know how they assume that with RLS, NRXP, and a potential 2nd molecule with UT news possible at any time.
|
|
|
Post by sportsrancho on Oct 18, 2021 10:46:32 GMT -5
Very true but I think we need to let this play out, we could get downgrades or something else could come out….🤷♀️
|
|
|
Post by joeypotsandpans on Oct 18, 2021 10:54:29 GMT -5
Those $4 put premiums will look even better if/when we slide into the 3s. For someone that is comfortable owning at effectively 2.75 I think selling @ 1.25 for the Jan '23 4 strike PUT at this point in the "wedge" is a nice ROI, only problem is if they really wanted to be long they're giving up far more ROI when this breaks the wedge to the upside. Curious how deep under 4 you think this will go...I might take you up on a friendly wager that we see 5 again before we see under 4 by the end of Oct....but given the current price you would have to give me some decent odds 😉
|
|
|
Post by peppy on Oct 18, 2021 10:57:00 GMT -5
Price is pulling back into the last swing low, and the swing low of $3.79 isn't in need of defending. UTHR got the label, out of this mess. Chances are the bottom line will hold, and price continues the triangle.
|
|
|
Post by sr71 on Oct 18, 2021 10:58:51 GMT -5
MNKD price went below the Lower Bollinger Band earlier this morning, coming off the Upper Band as late as Wednesday of last week. IMHO, we may near a good time to double down. Sold some near-term ITM Puts this morning, but the written Calls aren't low enough yet to suit me for re-purchase.
|
|
|
Post by olderteampt on Oct 18, 2021 11:01:33 GMT -5
Re let this play out. Here is one possibility. What if this falls into UTHR's plan. If FDA denial and price drops UTHR starts to buy up shares to help get discount on eventual buy out price. After acquiring a health amount of cheap shares UTHR announces they are buying out MNKD. The denial told them what needs to be fixed and decreased their risk.
|
|
|
Post by goyocafe on Oct 18, 2021 11:09:25 GMT -5
Very true but I think we need to let this play out, we could get downgrades or something else could come out….🤷♀️ Announcing successful formulation of Zyesami-DPI would certainly help right the ship.
|
|